5 Stocks That Set the Market on Fire This Week

The 5 hottest stocks that skyrocketed this week! See which are making headlines and why investors are buzzing.

Dec 07 2024

It's been an electrifying week in the markets, and several stocks have been lighting up screens and dominating conversations in trading circles. From breakthrough trial results to massive earnings beats, these stocks are making waves—and you’ll want to keep your eyes on them. Let’s dive into the Hottest Stocks of the Week, featuring TARA, PSQH, SOUN, CCRN, and CRDO.

$TARA Protara Therapeutics—The Secret’s Out!

This week, TARA transitioned from a whisper to a roar. Featured on Benzinga’s "Stock Whisper Index," Protara Therapeutics was already capturing the attention of savvy investors before its breakout moment. But what really ignited the stock was the positive results from its Phase 2 ADVANCED-2 trial for TARA-002, a promising bladder cancer therapy targeting NMIBC (Non-Muscle Invasive Bladder Cancer).

The stock skyrocketed over 100% on Thursday after the company’s announcement, proving that biotech breakthroughs still hold massive upside potential. With pre-market activity showing strong momentum and a surge in volume, TARA is officially on the radar of institutional and retail investors alike.

Biotech stocks can be volatile, but a mid-stage trial success puts TARA-002 closer to commercialization. If the momentum continues, TARA could become one of the biggest turnaround stories of the year.

$PSQH The Trump Jr. Effect—A Rollercoaster Ride

If drama was a stock, it would be PSQH this week. The microcap commerce and payments company made headlines after Donald Trump Jr. joined the board of directors, sending shares soaring a jaw-dropping 270% in a single session.

But with great surges come great corrections. News of a 7.8 million share offering sent the stock down over 30% pre-market the next day, reminding investors that microcaps are not for the faint of heart. Despite the dip, PSQH remains a high-risk, high-reward play, and Trump Jr.’s involvement has injected a new level of interest into this formerly under-the-radar stock.

For aggressive traders, volatility equals opportunity. Keep PSQH on your watchlist if you’re willing to stomach the swings.

$SOUN SoundHound AI—The AI Darling of 2024

Artificial intelligence stocks are red-hot, and SoundHound AI (SOUN) is leading the charge. The stock has surged 564% year-to-date, and this week alone saw another round of explosive gains. Why? The company announced the deployment of its voice AI Smart Ordering system at all 130 Torchy’s Tacos locations, showcasing real-world adoption of its cutting-edge technology.

Investors are buzzing about SoundHound’s ability to carve out a niche in the AI space, and the stock’s 30% surge on Thursday only solidified its status as a market favorite. With momentum firmly intact, the big question is whether SOUN can sustain its meteoric rise.

AI is a long-term growth theme, and SOUN is proving it has the chops to capitalize on this transformative trend. For traders, the volatility is thrilling. For investors, the growth potential is undeniable.

$CCRN Cross Country Healthcare—A Buyout Bonanza

Mergers and acquisitions are always exciting, and Cross Country Healthcare (CCRN) became the latest beneficiary. Shares rocketed after the company announced it would be acquired by Aya Healthcare for $18.61 per share in an all-cash deal, representing a 67% premium to its previous closing price.

For CCRN shareholders, this is a win-win. For traders, it’s a reminder that buyout rumors and announcements can be lucrative opportunities.

With the healthcare sector consolidating, keep an eye on similar names that could benefit from M&A activity. The premium paid for CCRN shows there’s still appetite for strategic deals.

$CRDO Credo Technology—AI’s Next Big Winner?

AI isn’t just about flashy software—it’s also about the infrastructure powering it. Enter Credo Technology Group (CRDO), which blew away expectations with its latest earnings report. The company reported non-GAAP EPS of $0.07, beating estimates by $0.02, and revenue of $72.03M, beating by $5.22M.

The real excitement came from management bullish guidance, citing an AI-driven inflection point and new cloud customers as key growth catalysts. Wall Street is taking notice

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!

Why Join?

Find out what 10,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

Signup Now!

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.